Your search for "vector vaccines" return 128 results.
Ceva acquires Vetech Laboratories, Inc. >
Move adds significant poultry vaccine to innovative portfolio
Instituto Sanidad Ganadera, Argentina acquired by Ceva >
New company will build on strong biological expertise and expand Ceva’s platform in South American zone.
Joint Venture agreement between Ceva and Huadu signed in Beijing >
“Ceva Huadu” to become Innovation & R&D platform for biologicals
Dr. Steve Chu joins Ceva after 25 years at Fort Dodge and Elanco >
Addition to talented team positions Ceva for continued growth.
Parasiticides >
75% of all emerging human infectious diseases are of animal origin. Thanks to its products, Ceva fight against the spread of infectious disease that can be transmitted from wild or domestic animals an...
Ceva opens new production facility in Lenexa, Kansas >
May 3, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce the May 3, 2011 opening of a new poultry vaccine production facility at its Biomune Campus in Lenexa, Kansas.
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
Ceva vector vaccine symposium now available as a web-seminar >
The highly successful vector vaccines symposium organized by Ceva this October in San Diego can now be viewed online.
Ceva conducts Global Vaccine Symposium - 2010, October 6-8th >
Do new technologies go with better poultry production and better global health ?